Spelling suggestions: "subject:"neck - cancer."" "subject:"neck - devancer.""
221 |
Exposition professionnelle aux solvants et risque de cancer des voies aéro-digestives supérieures / Occupational Exposure to Solvants and Risk of Head and Neck CancerBarul, Christine 21 December 2017 (has links)
Contexte : Le rôle de l’exposition professionnelle aux solvants dans la survenue de cancers des voies aéro-digestives supérieures (VADS), suggéré dans quelques études, n’a été que peu examiné, malgré leur utilisation très répandue en milieu de travail. Objectif : L’objectif de cette thèse état d’évaluer les associations entre les expositions professionnelles aux solvants et le risque de cancer des VADS. Méthodes : Ce travail est basé sur les données de l’étude Icare, une large étude cas-témoins en population générale conduite en France entre 2001-2007. L’analyse a été restreinte aux hommes et a porté sur 1857 cas de carcinome épidermoïde de la cavité buccale, du pharynx et du larynx, et 2780 témoins. L’histoire professionnelle détaillée ainsi que les consommations de tabac et d’alcool ont été recueillies par questionnaire. Les expositions aux solvants ont été évaluées à l’aide de matrices emplois-expositions et incluaient cinq solvants chlorés (perchloroéthylène, trichloroéthylène, chlorure de méthylène, chloroforme, tétrachlorure de carbone), cinq solvants pétroliers (benzène ; essences carburant ; gazole, fiouls et kérosène ; essences spéciales ; white spirits) et cinq solvants oxygénés (cétones et esters ; alcools ; éther éthylique ; éthylène glycol ; tétrahydrofurane). Les odds-ratios ajustés sur les consommations de tabac et d’alcool et d’autres facteurs de confusion potentiels, et les intervalles de confiances à 95% ont été estimés par régression logistique. Résultats : Aucune association significative n’a été mise en évidence entre exposition professionnelle aux solvants chlorés, pétroliers et oxygénés étudiés et le risque de cancer de l’ensemble des VADS. Dans l’analyse par localisation, le risque de cancer du larynx augmentait significativement avec l’exposition cumulée au perchloroéthylène. Des risques élevés de cancer de l’hypopharynx, bien que non significatifs, étaient observés pour les hommes exposés à des niveaux élevés de chlorure de méthylène, de white spirits et de tétrahydrofurane. Une association entre exposition au tétrahydrofurane et cancer de la cavité buccale était également suggérée. Aucune association claire n’était observée pour les autres solvants, quelle que soit la localisation de cancer. Conclusion : Des associations positives ont été observées avec plusieurs solvants spécifiques. Toutefois, dans l’ensemble, nos résultats ne sont pas en faveur d’un rôle majeur de l’exposition aux solvants dans la survenue de cancer des VADS. / Background : The role of occupational exposure to solvents in the risk of head and neck cancer has been suggested in some studies but has been few investigated, despite their widespread use in the workplace. Objective: The objective of this thesis was to examine the associations between occupational exposure to solvents and the risk of head and neck cancer. Methods: This work is based on data from the ICARE study, a large population-based case-control study conducted in France between 2001 and 2007. The analysis was restricted to men and included 1,857 cases of squamous cell carcinoma of the oral cavity, pharynx and larynx and 2,780 controls. Detailed occupational lifetime as well as alcohol and tobacco consumptions were collected by questionnaires. Exposure to solvents was assessed by job exposure matrices and included five chlorinated solvents (perchloroethylene, trichloroethylene, methylene chloride, chloroform, carbon tetrachloride), five petroleum-based solvents (benzene; gasoline; diesel, fuels and kerosene; special petroleum products; white spirits) and five oxygenated solvents (ketones and esters; alcohols; diethyl ether; ethylene glycol; tetrahydrofuran). Odds-ratios adjusted for smoking, alcohol drinking and other potential confounders and 95% confidence intervals were estimated with logistic models. Results: No significant association was found between occupational exposure to chlorinated, petroleum-based and oxygenated solvents and the risk of head and neck cancer overall. In subsite analysis, the risk of laryngeal cancer increased with cumulative exposure to perchloroethylene. Non-significantly elevated risks of hypopharyngeal cancer were found in men exposed to high cumulative levels of methylene chloride, white spirits and tetrahydrofuran. An association between exposure to tetrahydrofuran and oral cavity cancer was also suggested. No other clear association was found for the other solvents under study, for any cancer site. Conclusion: Although positive associations were observed for several solvents, overall the results do not suggest a substantial role of exposure to solvents in head and neck cancer risk.
|
222 |
Shoulder-Specific Patient Reported Outcome Measures for Use in Patients with Head and Neck Cancer:An Assessment of Reliability, Construct Validity, and Overall Appropriateness of Test Score Interpretation Using Rasch AnalysisEden, Melissa Michelle 01 December 2018 (has links)
Context: Medical management for head and neck cancer (HNC) often includes neck dissection surgery, a side effect of which is shoulder dysfunction. There is no consensus for which patient-reported outcome measure (PRO) is most appropriate to quantify shoulder dysfunction in this population.
Objective: The aims of this research study were to: (1) use Rasch methodologies to assess construct validity and overall appropriateness of test score interpretation of Disability of the Arm, Shoulder and Hand (DASH), QuickDASH, Shoulder Pain and Disability Index (SPADI) and Neck Dissection Impairment Index (NDII) in the HNC population; (2) determine appropriateness of use of University of Washington Quality of Life (UW-QoL) shoulder subscale as a screening tool for shoulder impairment; (3) recommend a new PRO, or combination of PROs, that more accurately portrays the construct of shoulder dysfunction in the HNC population.
Design: One hundred and eight-two individuals who had received a neck dissection procedure within the past 2 weeks to 18 months completed the PROs. Rasch methodologies were utilized to address the primary aim of the study through consideration of scale dimensionality [principal components analysis, item and person fit, differential item functioning (DIF)], scale hierarchy (gaps/redundancies, floor/ceiling effects, coverage of ability levels), response scale structure, and reliability (person and item reliability and separation statistics). The secondary aim was addressed through correlational analysis of the UW-QoL (shoulder subscale), DASH, QuickDASH, SPADI and NDII.
Results: The DASH did not meet criteria for unidimensionality, and was deemed inappropriate for utilization in this sample. The QuickDASH, SPADI and NDII were all determined to be unidimensional. All scales had varying issues with person and item misfit, DIF, coverage of ability levels, gaps/redundancies, and optimal rating scale requirements. The NDII meets most requirements. All measures were found to meet thresholds for person and item separation and reliability statistics. The third aim of this study was not addressed because the NDII was determined to be appropriate for this population.
Conclusions: Rasch analysis indicates the NDII is the most appropriate measure studied for this population. The QuickDASH and SPADI are recommended with reservation. The DASH and the UW-QoL (shoulder subscale) are not recommended.
|
223 |
Decision Support for Oropharyngeal Cancer Patients Based on Data-Driven Similarity Metrics for Medical Case ComparisonBuyer, Julia, Oeser, Alexander, Grieb, Nora, Dietz, Andreas, Neumuth, Thomas, Stoehr, Matthaeus 09 June 2023 (has links)
Making complex medical decisions is becoming an increasingly challenging task due to the growing amount of available evidence to consider and the higher demand for personalized treatment and patient care. IT systems for the provision of clinical decision support (CDS) can provide sustainable relief if decisions are automatically evaluated and processed. In this paper, we propose an approach for quantifying similarity between new and previously recorded medical cases to enable significant knowledge transfer for reasoning tasks on a patient-level. Methodologically, 102 medical cases with oropharyngeal carcinoma were analyzed retrospectively. Based on independent disease characteristics, patient-specific data vectors including relevant information entities for primary and adjuvant treatment decisions were created. Utilizing the ϕK correlation coefficient as the methodological foundation of our approach, we were able to determine the predictive impact of each characteristic, thus enabling significant reduction of the feature space to allow for further analysis of the intra-variable distances between the respective feature states. The results revealed a significant feature-space reduction from initially 19 down to only 6 diagnostic variables (ϕK correlation coefficient ≥ 0.3, ϕK significance test ≥ 2.5) for the primary and 7 variables (from initially 14) for the adjuvant treatment setting. Further investigation on the resulting characteristics showed a non-linear behavior in relation to the corresponding distances on intra-variable level. Through the implementation of a 10-fold cross-validation procedure, we were further able to identify 8 (primary treatment) matching cases with an evaluation score of 1.0 and 9 (adjuvant treatment) matching cases with an evaluation score of 0.957 based on their shared treatment procedure as the endpoint for similarity definition. Based on those promising results, we conclude that our proposed method for using data-driven similarity measures for application in medical decision-making is able to offer valuable assistance for physicians. Furthermore, we consider our approach as universal in regard to other clinical use-cases, which would allow for an easy-to-implement adaptation for a range of further medical decision-making scenarios.
|
224 |
Frailty Assessed with FRAIL Scale and G8 Questionnaire Predicts Severe Postoperative Complications in Patients Receiving Major Head and Neck SurgeryKunz, Viktor, Wichmann, Gunnar, Wald, Theresa, Pirlich, Markus, Zebralla, Veit, Dietz, Andreas, Wiegand, Susanne 04 December 2023 (has links)
Introduction: Frailty represents a complex geriatric syndrome associated with elevated
rates of postoperative complications as shown for several malignant entities, including head and neck
cancer. A specific screening instrument to assess frailty in head and neck patients does not exist. Both
the FRAIL Scale and the G8 questionnaire are well-established and easy to use as screening tools. The
present study’s aim was to assess the potential of frailty screening to predict postoperative complications in head and neck patients prior to surgery. Patients and methods: We recorded demographic
data, pre-existing medical conditions and clinical characteristics in a prospective cohort of 104 head
and neck cancer patients undergoing major head and neck surgery and assessed frailty prospectively
on the day of admission utilizing the G8 questionnaire and the FRAIL Scale. We analyzed the link
between occurrence of postoperative complications up to the twenty-first postoperative day and
age, frailty and other covariates using χ
2
tests and receiver operating characteristic (ROC) curves.
Results: There was no significant correlation between patients’ pre-existing medical conditions and
postoperative complications. Whereas chronological age alone did not predict the occurrence of
postoperative complications, frailty posed the highest risk for complications. Frailty according to
either the G8 questionnaire or the FRAIL Scale predicted occurrence of complications with an area
under the curve (AUC) of 0.64 (p = 0.018) and 0.62 (p = 0.039) and severe complications with an AUC
of 0.72 (p = 0.014) and 0.69 (p=0.031), respectively. Neither frailty score correlated with age or with
each other. Conclusion: Prospective screening using the FRAIL Scale or the G8 questionnaire reliably
detected frailty in our sample group. Frailty is linked to increased risk of postoperative complications.
The correct prediction of severe postoperative complications as shown identifies vulnerable cases and
triggers awareness of potential complications. Anticipating risk allows for a more comprehensive
view of the patient and triggers decision making towards risk adjustment, and therefore a selective
view of alternative treatment modalities.
|
225 |
Safety and Feasibility of Surgery for Oropharyngeal Cancers During the SARS-CoV-2-PandemicGorphe, Philippe, Grandbastien, Bruno, Dietz, Andreas, Duvvuri, Umamaheswar, Ferris, Robert L., Golusinski, Wojciech, Holsinger, Floyd Christopher, Hosal, Sefik, Lawson, George, Mehanna, Hisham, Paleri, Vinidh, Shaw, Richard, Succo, Giovanni, Leemanns, C. René, Simon, Christian 28 March 2023 (has links)
No description available.
|
226 |
Post radiation therapy hypothyroidism in patients with head and neck cancer at Pietersburg Hospital, Limpopo Province, South AfricaManavalan, Tijo Jospaul Davis January 2022 (has links)
Thesis (M.Med. (Radiation Oncology)) -- University of Limpopo, 2022 / Background
Hypothyroidism in head and neck cancer patients after radiotherapy is known to
occur, yet thyroid function tests are not routinely monitored in all patients post
radiation therapy. Routine post radiation therapy thyroid function testing is currently
not part of the follow-up protocol in these patients at Pietersburg Hospital.
The aim of this study is to evaluate post radiation therapy hypothyroidism among head
and neck cancer patients treated with radiotherapy at Pietersburg Hospital
Methods
A prospective (cohort) observational study was carried out among head and neck
cancer patients receiving radiotherapy at the radiation oncology department in
Pietersburg Hospital. Sample size of n=37 was calculated using Statistica V13.0.
Thyroid function tests were performed at the start of radiation therapy and repeated
on the first day of follow up, 6 weeks after completing radiation therapy. During follow up, participants were also interviewed for the presence of symptoms of
hypothyroidism such as dry skin, dry hair, fatigue, cold intolerance, or weight gain.
Data analysis was done with STATA version 16. Descriptive statistics were used to
characterise variables, and summarised in tables, graphs and charts. Changes in
thyroid function tests and other variables were analysed. A p-value of 0.05 was
deemed statistically significant.
Results
Thirty-seven patients were enrolled in the study, 26 males and 11 females. The mean
age of the patients was 53.1 ±12.3 standard deviation [SD]) with a range of 40.8 to
65.4 years. The most common diagnoses were cancer of the larynx and hypopharynx,
forming 29.7% and oral cavity cancer, 29.7%. Only three patients (8%) had an early stage cancer (Stages 1 and 2), 11 patients (29.7%) moderately advanced cancer
(Stage 3) while the majority (62%; n =23) had locally advanced cancer (Stage 4).
Majority of the patients received 70Gy in 35 daily fractions, five fractions per week via
3-D conformal radiotherapy. Only 29 patients who had complete pre- and post radiotherapy thyroid function tests were included in the final analysis. Of these, none
had clinical hypothyroidism at 3 months. Two patients (6.8%) had sub-clinical
hypothyroidism, with post radiation therapy TSH values greater than 3.5mIU/ml. The
mean post radiation therapy TSH values increased by 8.3% and the mean fT4 values
decreased by 2.05% compared to the pre-radiation therapy values. Both changes
were not statistically significant (p=0.99 and p=0.82 respectively). There was no
statistically significant correlation between changes in TSH and fT4 versus age
(p=0.88 and p=0.92 respectively), sex (p=0.55 and p=0.15 respectively), cancer stage
(p=0.21 and p=0.78 respectively), and cancer site (p=0.17 and p=0.74 respectively).
The most common post radiotherapy symptom was fatigue (62%) followed by cold
intolerance (54%), weight gain (43%) and dry skin or dry hair (43% each).
Conclusion
The results of the study suggest that sub-clinical hypothyroidism is detectable early
post radiation therapy presenting as clinical symptoms.
|
227 |
"Att hitta nyckeln" Sjuksköterskor erfarenheter av att vårda patienter med huvud-, halscancer och alkoholmissbruk. : En kvalitativ intervjustudie / ”To find the key” - Nurses experiences in caring for patientswith head-, neck cancer and alcohol abuse. : A qualitative interview stydyEnström, Jessica, Söderman, Frans January 2017 (has links)
Syfte: Att beskriva sjuksköterskors erfarenheter av att vårda patienter med huvud- och halscancer och alkoholmissbruk. Bakgrund: Cancer i huvud-halsområdet är den sjätte vanligaste dödsorsaken vid cancersjukdom. Överkonsumtion av alkohol tillsammans med rökning är de största enskilda riskfaktorerna för den här sjukdomen. Inom patientgruppen finns en stor representation av personer med ett risk- eller missbruk av alkohol, vilket ställer speciella krav på omvårdnadspersonalen. Design: Kvalitativ intervjustudie. Metod: Nio sjuksköterskor deltog i semistrukturerade intervjuer. Intervjuerna bandades och transkriberades sedan ordagrant innan de analyserades med tematisk-narrativ metod. Resultat: Sjuksköterskornas erfarenheter fångades i tre huvudteman: en mångfacetterad sjuksköterskeuppgift, den komplexa patienten och missbrukets påverkan på patienten. En mångfacetterad sjuksköterskeuppgift består av många delar. Den största delen bestod av berättelser om förhållningssätt och interaktion med patienter, behovet av kompetens hos sjuksköterskorna och svårigheter kring att motivera patienten, en annan handlar om bristen på samarbete med andra kliniker. Även kontakt med anhöriga berörs.Kring den komplexa patienten handlade det om känslor, nutritionsproblem, smärta och att de sågs som utmanande människor. Missbrukets påverkan på patienten bestod av patienternas kamp att hålla sig nyktra under behandlingsperioden, likväl som de anpassningar som sjuksköterskorna blev tvungna att göra i omvårdnaden av dem. Slutsats: Denna studie visade att det fanns ett behov av ökad kompetens hos sjuksköterskor och ett bättre samarbete mellan kliniker. Verktyg för att tala med patienter kring deras missbruk och vikten av en god relation betonas. Slutligen pekades på behovet av ytterligare forskning för att förbättra omvårdnaden av huvud-halscancerpatienter med alkoholmissbruk.
|
228 |
Genotoxic effects of a novel form of Gold Nanoparticles loaded with Hesperidin on head and neck cancer lymphocytes compared to effects from healthy control lymphocytes and Squamous cell Carcinoma of Maxillary sinusFida, Mehwish January 2023 (has links)
The head and neck cancers (HNC) are a group of cancers that begin in the squamous cells that line the mucosal surfaces of the head and neck. Therefore, they are commonly known as squamous cell carcinoma of the head and neck. Squamous cell carcinoma of the maxillary sinus (MC) is a rare type of HNC, and it is a very aggressive tumour. This cancer is typically diagnosed at a very advanced stage and most patients have a poor survival rate and prognosis. This study is based on the synthesis and applications of gold nanoparticles (AuNPs) conjugated with hesperidin (Hsp) as a targeted drug delivery system. AuNPs are ideal for loading different drugs and delivering them to targets sites due to their stability, small size, substantial surface area, non-cytotoxic and inert nature. Hsp is a naturally occurring substance with anti-inflammatory and antioxidant capabilities. The main aim of this research was to develop a highly efficient and safer method to deliver Hsp to the target sites. The Hsp with poor solubility and bioavailability render it only slightly absorbed, requiring a delivery system to reach its therapeutic target.
This study focused on the effects of 15μg/ml Hsp loaded on gold nanoparticles (Hsp-AuNPs) on 20 healthy individuals’ lymphocytes as compared to 20 HNC patients’ lymphocytes using the alkaline Comet assay. While enzyme-based Comet repair was performed on 5 healthy individuals’ lymphocytes as compared to 5 HNC patients’ lymphocytes. The Hsp-AuNPs reduced the DNA damage in HNC patients’ lymphocytes compared to the healthy lymphocytes (***p<0.001). Furthermore, the 15μg/ml of Hsp-AuNPs significantly reduced the oxidative stress caused by H2O2 and appeared to be effective in both groups using the Comet and Comet repair assay. Results from Comet and Comet repair assay were consistent. The human squamous cells of maxillary sinus (MC) were also treated with 5μg/ml of Hsp-AuNPs. The alkaline Comet assay results showed that Hsp-AuNPs induced DNA damage in MC cells (***p<0.001). Therefore, Hsp-AuNPs demonstrated the most substantial genotoxic effects and confirmed a possible anticancer agent. The Hsp was also used to treat lymphocytes from healthy individuals as compared to HNC patients’ lymphocytes they reduced the DNA damage, but they were less effective as compared to Hsp-AuNPs. Published data shows that using the AuNPs as a drug carrier has a more potent therapeutic effect against different diseases including cancer. Also, this study investigated the gene protective and genotoxic impact of bulk Hsp in Maxillary sinus carcinoma cells. The data obtained indicated that Hsp-AuNPs might possibly be effective for the treatment of MC and demonstrated the ability of Hsp-AuNPs to increase the DNA damage more than the bulk form of Hsp (***p<0.001). The outcomes of this study are consistent with the viewpoint that the Hsp-AuNPs might have a substantial role in cancer treatment, including MC. The concentration of 5μg/ml Hsp-AuNPs was used to treat the MC cells in Western blotting, and real-time polymerase chain reaction (qPCR) was based on a preliminary test for the optimal dose. The data obtained indicated that Hsp-AuNPs might potentially be effective for the treatment of HNC and showed the ability of Hsp-AuNPs to reduce DNA damage more than the bulk form of Hsp. Hsp-AuNPs has also shown anti-cancer potential in the MC cells by up-regulating the expression of p53, p21, PPAR gamma, and Caspase 3, at mRNA and protein levels by up-regulating the p53, PPAR gamma, Caspase 3, and p21 to mediate apoptosis and DNA repair in MC cells. The findings of this study are consistent with the view that the Hsp-AuNPs could have a significant role in cancer treatment, including HNC and MC.
|
229 |
Molekularzytogenetische Charakterisierung von Plattenepithelkarzinomen des Kopf-Hals-BereichesBockmühl, Ulrike 01 January 1999 (has links)
Ziel der Habilarbeit war die molekulargenetische und -zytogenetische Charakterisierung von Kopf-Hals-Karzinomen, um das biologische Verhalten dieser Tumoren besser einschätzen zu können als mit Hilfe der bekannten klinisch-pathologischen Tumorklassifikation. Dazu wurden 100 primäre Plattenepithelkarzinome des Kopf-Hals-Bereiches, 27 Fälle syn- oder metachroner Metastasen und 10 Fälle von Zweitkarzinomen mit Hilfe der Comparativen Genomischen Hybridisierung (CGH) analysiert. Alle untersuchten Tumoren stammten von Patienten, die primär im Zeitraum zwischen 1994 und 1998 in der HNO-Klinik der Charité operiert wurden. Die Auswertung der analysierten Tumoren brachte die nachfolgenden wesentlichen Ergebnisse: Plattenepithelkarzinome des Kopf-Hals-Bereiches sind durch Deletionen der Chromosomen 3p, 4p/q, 5q, 6q, 8p, 9p, 11p/q, 13q, 18q und 21q sowie DNA-Gewinne im Bereich von 1p, 3q, 5p, 8q, 9q, 11q13, 16p, 17q, 19, 20q und 22q. Gut differenzierte Tumoren sind durch Deletionen auf Chromosom 3p und 9p kombiniert mit einem DNA-Gewinn auf 3q gekennzeichnet. Die schlecht differenzierten Malignome zeigen zusätzlich die Deletionen von Chromosom 4, 5q, 8p, 11, 13q, 18q sowie 21q und die DNA-Gewinne von 8q, 11q13 sowie 20q.Der metastatische Phänotyp ist bei Kopf-Hals-Karzinomen durch Deletionen im Bereich der Chromosomen 10q und 11 charakterisiert.Als wichtigstes Ergebnis konnten zwei unabhängige genetische Prognosemarker für Kopf-Hals-Karzinome charakterisiert werden - die 11q13- und 3q-Amplifikation. In der multivariaten Cox-Regression zeigte sich, daß der Einfluß beider Parameter, besonders aber der 11q13-Amplifikation für die Einschätzung des rezidiv- und metastasenfreien sowie des Gesamtüberlebens der Patienten größer ist als der aller klinisch-pathologischen Parameter, insbesondere der TNM-Klassifikation. / Comparative Genomic Hybridization (CGH) was performed on 100 primary head and neck squamous cell carcinomas, 27 cases of lymph node metastases and 10 second primaries. The main results are summarized as follows: The entity of head and neck squamous cell carcinomas is characterized by a pattern of chromosomal alterations involving deletions chromosomes 3p, 4p/q, 5q, 6q, 8p, 9p, 11p/q, 13q, 18q and 21q combined with overrepresentations of chromosomes 1p, 3q, 5p, 8q, 9q, 11q13, 16p, 17q, 19, 20q and 22q.Well differentiated carcinomas (G1) carry deletions on chromosomes 3p and 9p together with the overrepresentation of 3q indicating early tumor development. Accordingly, the undifferentiated tumors (G3) were charaterized by addtional deletions on chromosomes 4, 5q, 8p, 11, 13q, 18q, 21q and overrepresentations on 8q, 11q13 and 20q suggesting that these changes are preferentially associated with tumor progression.The metastatic phenotype of head and neck suqamous cell carcinomas is significantly associated with deletions of chromosomes 10q and 11.The overall survival time as well as the recurrence free survival time were significantly lower in patients who's tumors showed amplifications of the chromosomal region 11q13 and/or overrepresentations of chromosome 3q (tested for significance by the log rank test p=0.0008 / p=0.0299). Multivariate analysis (Cox's proportional hazards model) revealed both chromosomal alterations as most important independent prognostic factors in HNSCC prior to the established TNM staging system.
|
230 |
Μοριακή ανάλυση και διαπίστωση μεταβολών δομικών και λειτουργικών μακρομοριακών συστατικών στον καρκίνο του λάρυγγαΤσιρόπουλος, Γαβριήλ 11 October 2013 (has links)
Εισαγωγή: Ο καρκίνος του λάρυγγα, ιδιαιτέρως σε προχωρημένα στάδια, είναι μία καταστροφική νόσος η οποία χαρακτηρίζεται από αυξημένη διηθητικότητα και μεταστατικότητα. Η ανεύρεση ενός δείκτη πρώιμης διάγνωσης, παρακολούθησης και πρόγνωσης της νόσου θα ήταν ιδιαίτερα ευπρόσδεκτη. Συνεχώς αυξανόμενα δεδομένα στη βιβλιογραφία υποστηρίζουν την προγνωστική αξία των ζελατινασών και τον πιθανό ρόλο τους ως μοριακών δεικτών μεταξύ άλλων και στον καρκίνο του λάρυγγα.
Σκοπός: Η διαπίστωση μεταβολών στα επίπεδα ορού των ζελατινασών Α και Β σε ασθενείς με καρκίνο του λάρυγγα μετά από εφαρμογή θεραπείας, καθώς και η πιθανή συσχέτιση με διάφορες κλινικοπαθολογικές παραμέτρους πριν και μετά τη θεραπευτική παρέμβαση.
Υλικό και μέθοδος: Σαράντα εννέα ασθενείς και 8 υγιείς μάρτυρες συμπεριλήφθηκαν στη μελέτη. Ελήφθησαν προεγχειρητικά και μετεγχειρητικά δείγματα ορού τα οποία στη συνέχεια υποβλήθηκαν σε ζυμογραφία ζελατίνης. Η παρουσία ζελατινασών επιβεβαιώθηκε με την τεχνική western blotting. Οι ζώνες λύσης ποσοτικοποιήθηκαν με τη χρήση Scion Image PC. Η ανάλυση των αποτελεσμάτων πραγματοποιήθηκε με το πρόγραμμα SPSS 17 (SPSS Inc, Chicago, IL, USA).
Αποτελέσματα: Στα ζυμογραφήματα αποτυπώθηκαν μόνο οι λανθάνουσες μορφές των ενζύμων (προένζυμα). Τα προ της θεραπείας επίπεδα και των δύο ζελατινασών στον ορό του αίματος των ασθενών με καρκίνο του λάρυγγα ήταν σημαντικά υψηλότερα σε σχέση με αυτά των υγιών μαρτύρων. Ασθενείς με υπεργλωττιδικό καρκίνωμα και ενεργοί καπνιστές είχαν σημαντικά υψηλότερα επίπεδα proMMP-2 σε σχέση με ασθενείς που έπασχαν από γλωττιδικό καρκίνωμα και με πρώην καπνιστές αντίστοιχα. Ασθενείς με πρωτοδιαγνωσμένη νόσο και ασθενείς με λεμφαδενικές μεταστάσεις είχαν σημαντικά χαμηλότερα προ της θεραπείας επίπεδα proMMP-9 σε σχέση με ασθενείς που προσήλθαν με υποτροπή και με ασθενείς στους οποίους δεν διαπιστώθηκε επιχώρια νόσος αντίστοιχα. Κατά τη διάρκεια της συστηματικής παρακολούθησης τα επίπεδα της proMMP-2 στον ορό παρουσίασαν σημαντική αύξηση τις πρώτες 10 με 15 ημέρες μετά την εφαρμογή θεραπείας, για να μειωθούν σταδιακά εντός των επόμενων μηνών. Οι ενεργοί καπνιστές παρουσίασαν σημαντική μείωση των επιπέδων της proMMP-2 κατά την περίοδο παρακολούθησης, σε αντίθεση με τους πρώην καπνιστές οι οποίοι εμφάνισαν σημαντική αύξηση κατά το ίδιο χρονικό διάστημα. Οι ασθενείς σταδίου ΙΙ είχαν σημαντικά χαμηλότερα επίπεδα proMMP-2 σε σχέση με ασθενείς προχωρημένων σταδίων πέντε με οκτώ μήνες μετά τη θεραπεία, όπως και οι ασθενείς οι οποίοι υποβλήθηκαν σε συντηρητική αντιμετώπιση σε σχέση με τους χειρουργημένους ασθενείς. Τα επίπεδα της proMMP-9 στον ορό επίσης παρουσίασαν σημαντική πτώση μετά την εφαρμογή θεραπείας. Διαφορές στο ρυθμό μείωσης των επιπέδων της proMMP-9 παρατηρήθηκαν μεταξύ των διαφόρων ομάδων ως προς το στάδιο, τη διαφοροποίηση, την εντόπιση, τον τύπο της νόσου (πρωτοδιαγνωσμένη ή υποτροπή), τις λεμφαδενικές μεταστάσεις, τον τρόπο αντιμετώπισης και την κατανάλωση αλκοόλ. Ωστόσο αυτή η διαφορά δεν διατηρήθηκε πέντε με οκτώ μήνες μετά την εφαρμογή θεραπείας, με εξαίρεση την ομάδα των χειρουργημένων ασθενών, οι οποίοι διατήρησαν σημαντικά υψηλότερα επίπεδα ενζύμου στον ορό. Αύξηση των ζελατινασών παρατηρήθηκε στον ορό ασθενών που εκδήλωσαν υποτροπή μετά από αντιμετώπιση πρωτοδιαγνωσμένης νόσου σε σχέση με αυτούς που δεν υποτροπίασαν. Ωστόσο εξαιτίας του μικρού δείγματος δεν είναι δυνατόν να εξαχθούν ασφαλή συμπεράσματα.
Συμπεράσματα: Αν και δεν υφίστανται φυσιολογικές τιμές, το πρότυπο μεταβολής των επιπέδων της proMMP-9 στον ορό μετά από θεραπεία καταδεικνύει πιθανές ιδιότητες μοριακού δείκτη. Ωστόσο υπάρχουν ενδείξεις ότι και οι δύο ζελατινάσες θα μπορούσαν να χρησιμοποιηθούν για την εξατομικευμένη παρακολούθηση ασθενών με καρκίνο του λάρυγγα. Περαιτέρω έρευνα απαιτείται για την αποσαφήνιση του ζητήματος. / Introduction: Laryngeal cancer, especially in the advanced stages, is a highly devastating disease, characterized by increased invasiveness and high rates of metastasis. The identification of reliable tumour marker for prompt diagnosis, surveillance and prognosis would be highly desirable. There is a growing body of evidence with regard to the prognostic value of gelatinases and their possible role as tumour markers.
Aim: To identify the pattern of alteration of serum gelatinases A and B in patients with laryngeal cancer following treatment, and a possible correlation with various clinicopathological parameters prior to and past treatment.
Materials and methods: Forty nine patients and 8 healthy controls were included in the study. Pre-treatment and post-treatment serum samples were collected and processed by gelatin zymography. The presence of gelatinases was verified by western blotting. The zymograms were scanned by a digital scanner and the lysis bands were quantified by Scion Image PC. Analysis of the quantitative results was performed by using SPSS 17 (SPSS Inc, Chicago, IL, USA).
Results: Only the latent forms of MMP-2 and -9 (proforms) were identified. Both gelatinases were increased in the serum of laryngeal cancer patients compared to healthy individuals. Patients with supraglottic tumours and active smokers had significantly higher pre-treatment levels of proMMP-2 than patients with glottic tumours and ex-smokers, respectively. Patients with primary disease and patients with lymph node involvement showed lower proMMP-9 pre-treatment levels than patients with recurrence and patients without neck disease, respectively. During the follow-up period the proMMP-2 serum levels increased significantly in the first ten to fifteen days after treatment, gradually decreasing over the following months. Smokers showed a very high decrease rate of proMMP-2 levels during the follow-up period, whereas in ex-smokers proMMP-2 levels significantly increased. Stage II patients showed significantly lower levels of circulating enzyme compared to patients with more advanced disease five to eight months past treatment. Similarly, conservative management was associated with lower levels of serum proMMP-2 compared to surgical management five to eight months following treatment. The proMMP-9 serum levels also showed a gradual decrease after treatment, which was statistically significant. Significant alterations in the rate of decrease developed among groups with regard to stage, grade, location, type of disease (primary or recurrence), regional disease, treatment modality and alcohol consumption. Nevertheless those differences were not maintained five to eight months past treatment, with the exception of patients who underwent surgery and who maintained higher levels of proMMP-9. An increase to the levels of both gelatinases were observed in patients with recurrent disease after having been treated for a primary compared to patients who did not develop a recurrence. However, the small sample of patients with recurrent disease during the follow-up period does not allow extrapolating sound conclusions.
Conclusions: Although as yet normal values have not been established in the literature, the post-treatment alteration pattern of proMMP-9 serum levels indicates that this enzyme might play a role as a tumour marker. Nevertheless this study provides evidence that both gelatinases might be useful for surveillance on strictly individual basis in laryngeal cancer patients. Further research is necessary to clarify the contribution of both gelatinases to the disease progress and determine their role as prognostic factors and tumour markers.
|
Page generated in 0.3118 seconds